RN.AI Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
RN.AI Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at RN.AI Therapeutics
Justin S. Antony
Co-Founder & CEO
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About RN.AI Therapeutics
RN.AI Therapeutics is a pre-seed stage Helmholtz spin-off based in Munich. We are pioneering AI-driven target discovery to enable precision combination therapies for inflammatory and immunological diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
RN.AI Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
RN.AI Therapeutics has never raised funding before.
United States
Netherlands
Italy
Mexico
South Africa
United Kingdom
DenmarkFrequently asked questions
RN.AI Therapeutics is located in XX.
RN.AI Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
RN.AI Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
RN.AI Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
RN.AI Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
